Anrs, Emerging Infectious Diseases
Clinical trials sponsored by Anrs, Emerging Infectious Diseases, explained in plain language.
-
Major study tests 12-Week cure for hepatitis c in cambodian youth
Disease control OngoingThis study aims to test how well a 12-week combination pill (sofosbuvir/daclatasvir) works to clear the Hepatitis C virus in children and teenagers in Cambodia. It will involve up to 21,000 young people, first screening them for the virus and then treating those who are infected.…
Phase: NA • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Disease control
Last updated Apr 01, 2026 21:26 UTC
-
New push to wipe out hepatitis c in hidden High-Risk communities
Disease control OngoingThis study is testing a community outreach program to find and treat hepatitis C (HCV) in people who use drugs in four French cities. It uses a 'peer recruitment' method where participants invite others to get screened and receive immediate treatment if needed. The goal is to see…
Phase: NA • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Can exercise fight disability in older adults with HIV?
Symptom relief OngoingThis study is testing whether structured exercise programs can help older adults living with HIV in Côte d'Ivoire stay mobile and independent. It compares a group exercise class, a home-based program with phone support, and general health education. The goal is to see which appro…
Phase: NA • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Symptom relief
Last updated Mar 19, 2026 14:55 UTC